Euro vs US Dollar

Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.

Registrieren

AUPH Aurinia Pharmaceuticals Inc

8,185

0,035 (0,43%)

Zuletzt aktualisiert: 17:56:10

Verzögert um 15 Minuten

Form 3 - Initial statement of beneficial ownership of securities

Aurinia Pharmaceuticals (NASDAQ:AUPH)
Historical Stock Chart
Von Feb 2025 bis Mär 2025

Click Here for more Aurinia Pharmaceuticals Charts.

Aurinia Pharmaceuticals (NASDAQ:AUPH)
Historical Stock Chart
Von Mär 2024 bis Mär 2025

Click Here for more Aurinia Pharmaceuticals Charts.

News Aurinia Pharmaceuticals Inc

Form 4 - Statement of changes in beneficial ownership of securities
Freitag 7 März 2025 (6 Tage vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Mittwoch 5 März 2025 (1 Woche vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Mittwoch 5 März 2025 (1 Woche vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Mittwoch 5 März 2025 (1 Woche vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Mittwoch 5 März 2025 (1 Woche vor) • Edgar (US Regulatory)

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Donnerstag 27 Februar 2025 (2 Wochen vor) • Edgar (US Regulatory)

Form 8-K - Current report
Donnerstag 27 Februar 2025 (2 Wochen vor) • Edgar (US Regulatory)

Aurinia Pharmaceuticals Reports Financial Results for the Three and Twelve Months Ended December 31, 2024 and Provides Update on Recent Corporate Progress
Donnerstag 27 Februar 2025 (2 Wochen vor) • Business Wire

Aurinia Pharmaceuticals to Release 2024 Fourth Quarter and Full Year Financial and Operational Results on February 27, 2025
Donnerstag 20 Februar 2025 (3 Wochen vor) • Business Wire

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Freitag 14 Februar 2025 (4 Wochen vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Montag 25 November 2024 (4 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Montag 25 November 2024 (4 Monate vor) • Edgar (US Regulatory)

Weitere Aurinia Pharmaceuticals Inc News-Artikel

WisdomTree Multi Asset I...

Societe Generale Effekten

Societe Generale Effekten

Virgin Galactic

Leonteq Securities

Societe Generale Effekten

Societe Generale Effekten

Wti Crude Oil 2x Daily L...

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen